UCB to sponsor trials at ‘giant site without borders’

By Flora Southey contact

- Last updated on GMT

(Image: Getty/oatawa)
(Image: Getty/oatawa)
Neurology and immunology trial participants will undertake "site-less" clinical trials under a partnership between Science 37 and drugmaker UCB.

According to the strategic collaboration, UCB-sponsored studies will use Science 37’s mobile research platform, the Network Oriented Research Assistant (NORA), to offer "site-less" trials.

The decentralized​ "Metasite" clinical trial model engages with subjects remotely to encourage greater retention of participants and reduce recruitment times.

“Science 37 is made up of one-part in-house technology team, the rest is a decentralized physician network who connect directly to patients 24/7/375 using our proprietary mobile platform,” ​explained Science 37 CEO Belinda Tan.

“We think of ourselves as a giant site without borders,” ​she added.

The partnership will also help UCB-sponsored studies reach remote or underserved communities, we were told.

The first ‘site-less’ UCB trial for Paediatric restless leg syndrome (RLS) is expected to begin this year.

Strategic collaborations

Science 37’s Metasite platform is attracting increased attention in the clinical development space. 

In December last year, Otsuka Pharmaceutical announced​ a strategic collaboration to explore the patient-centric trial method.

Additionally, in March 2018 Novartis​ – an early investor​ in Science 37 – committed​ to conducting up to ten clinical trials to scale up the "site-less" model.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars